Csenge Advisory Group’s Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share JEMD Stock Holding History

Csenge Advisory Group’s Portfolio JEMD Stock Details JEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-21,270	Closed	-$137K	–	679
2022 Q3	$137K	Sell	21,270 -857	-4%	-$5.61K	0.01%	583
2022 Q2	$148K	Sell	22,127 -49,579	-69%	-$343K	0.01%	550
2022 Q1	$502K	Sell	71,706 -5,994	-8%	-$43.5K	0.04%	377
2021 Q4	$631K	Buy	77,700 +5,902	+8%	+$45.8K	0.06%	288
2021 Q3	$572K	Sell	71,798 -5,902	-8%	-$47.8K	0.05%	337
2021 Q2	$631K	Buy	77,700 +340	+0.4%	+$2.76K	0.06%	289
2021 Q1	$619K	Buy	77,360 +7,108	+10%	+$55.4K	0.06%	234
2020 Q4	$525K	Buy	70,252 +26,717	+61%	+$196K	0.06%	217
2020 Q3	$323K	Buy	+43,535	New	+$324K	0.04%	290

Csenge Advisory Group's JEMD Position: Q4 2022 in Review

Csenge Advisory Group sold out of Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share (JEMD) in Q4 2022, closing a stake of 21,270 shares — an estimated $137K sold.

Csenge Advisory Group first reported a position in JEMD in Q3 2020 and held it in 9 quarters. The position peaked at $631K in Q4 2021. 0 funds tracked by Wall St. Rank hold JEMD as of Q4 2022.

Csenge Advisory Group reported no remaining Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share position as of Q4 2022 after selling out during the quarter.
Csenge Advisory Group sold 21,270 Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share shares in Q4 2022, an estimated $137K.
Csenge Advisory Group first reported a position in Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share in Q3 2020 and held it in 9 quarters.
Csenge Advisory Group's Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share position peaked at $631K in Q4 2021.
0 funds tracked by Wall St. Rank held Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share as of Q4 2022.

Based on Csenge Advisory Group's 13F filing for Q4 2022, filed 10 Feb 2023.